Brent Pfeiffenberger is President and CEO of Century Therapeutics, Inc.. Currently has a direct ownership of 1.23 Million shares of IPSC, which is worth approximately $1.35 Million. The most recent transaction as insider was on Dec 04, 2024, when has been sold 243,447 shares (Common Stock) at a price of $1.44 per share, resulting in proceeds of $350,563. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.23M
16.55% 3M change
15.55% 12M change
Total Value Held $1.35 Million

Brent Pfeiffenberger Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 04 2024
SELL
Payment of exercise price or tax liability
$350,563 $1.44 p/Share
243,447 Reduced 16.55%
1,227,257 Common Stock
Mar 07 2024
BUY
Grant, award, or other acquisition
-
17,425 Added 1.17%
1,470,704 Common Stock
Dec 04 2023
BUY
Grant, award, or other acquisition
-
1,453,279 Added 50.0%
1,453,279 Common Stock

Also insider at

BFLY
Butterfly Network, Inc. Healthcare
BP

Brent Pfeiffenberger

President and CEO
Philadelphia, PA

Track Institutional and Insider Activities on IPSC

Follow Century Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IPSC shares.

Notify only if

Insider Trading

Get notified when an Century Therapeutics, Inc. insider buys or sells IPSC shares.

Notify only if

News

Receive news related to Century Therapeutics, Inc.

Track Activities on IPSC